A B Sawatzke1, A W Norris2, F Spyropoulos1, S A Walsh3, M R Acevedo3, S Hu1, J Yao1, C Wang1, J J Sunderland3, L L Boles Ponto3. 1. Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. 2. Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. Electronic address: andrew-norris@uiowa.edu. 3. Small Animal Imaging Core, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
Abstract
INTRODUCTION: The goal of this study was to define the kinetics of glucose transport from maternal blood to placenta to fetus using real time imaging. METHODS: Positron emission tomography (PET) imaging of the glucose-tracer [(18)F]fluorodeoxyglucose (FDG) was used to temporally and spatially define, in vivo, the kinetics of glucose transport from maternal blood into placentae and fetuses, in the late gestational gravid rat. Computed tomography (CT), with intravenous contrast, co-registered to the PET images allowed anatomic differentiation of placentae from fetal and maternal tissues. RESULTS: FDG was rapidly taken up by placentae and subsequently appeared in fetuses with minimal temporal lag. FDG standardized uptake values in placentae and fetuses approached that of maternal brain. In both anesthetized and awake dams, one quarter of the administered FDG ultimately was accrued in the collective fetuses and placentae. Accordingly, kinetic modeling demonstrated that the placentae had very high avidity for FDG, 2-fold greater than that of the fetus and maternal brain, when accounting for the fact that fetal FDG necessarily must first be taken up by placentae. Consistent with this, placental expression of glucose transporter 1 exceeded that of all other tissues. DISCUSSION: Fetal and placental tissues place a substantial glucose metabolic burden on the mother, owing to very high avidity of placentae for glucose coupled with the large relative mass of fetal and placental tissues. CONCLUSIONS: The placenta has a tremendous capacity to uptake and transport glucose. PET/CT imaging is an ideal means to study metabolite transport kinetics in the fetoplacental unit.
INTRODUCTION: The goal of this study was to define the kinetics of glucose transport from maternal blood to placenta to fetus using real time imaging. METHODS: Positron emission tomography (PET) imaging of the glucose-tracer [(18)F]fluorodeoxyglucose (FDG) was used to temporally and spatially define, in vivo, the kinetics of glucose transport from maternal blood into placentae and fetuses, in the late gestational gravid rat. Computed tomography (CT), with intravenous contrast, co-registered to the PET images allowed anatomic differentiation of placentae from fetal and maternal tissues. RESULTS:FDG was rapidly taken up by placentae and subsequently appeared in fetuses with minimal temporal lag. FDG standardized uptake values in placentae and fetuses approached that of maternal brain. In both anesthetized and awake dams, one quarter of the administered FDG ultimately was accrued in the collective fetuses and placentae. Accordingly, kinetic modeling demonstrated that the placentae had very high avidity for FDG, 2-fold greater than that of the fetus and maternal brain, when accounting for the fact that fetal FDG necessarily must first be taken up by placentae. Consistent with this, placental expression of glucose transporter 1 exceeded that of all other tissues. DISCUSSION: Fetal and placental tissues place a substantial glucose metabolic burden on the mother, owing to very high avidity of placentae for glucose coupled with the large relative mass of fetal and placental tissues. CONCLUSIONS: The placenta has a tremendous capacity to uptake and transport glucose. PET/CT imaging is an ideal means to study metabolite transport kinetics in the fetoplacental unit.
Authors: Amit Ganguly; Robert A McKnight; Santanu Raychaudhuri; Bo-Chul Shin; Zhigui Ma; Kelle Moley; Sherin U Devaskar Journal: Am J Physiol Endocrinol Metab Date: 2007-01-09 Impact factor: 4.310
Authors: Edith W M T ter Braak; Inge M Evers; D Willem Erkelens; Gerard H A Visser Journal: Diabetes Metab Res Rev Date: 2002 Mar-Apr Impact factor: 4.876
Authors: Andrew W Norris; Chunlin Wang; Jianrong Yao; Susan A Walsh; Alexander B Sawatzke; Shanming Hu; John J Sunderland; Jeffrey L Segar; Laura L B Ponto Journal: Endocrinology Date: 2010-11-17 Impact factor: 4.736
Authors: Jianrong Yao; Chunlin Wang; Susan A Walsh; Shanming Hu; Alexander B Sawatzke; Diana Dang; Jeffrey L Segar; Laura L B Ponto; John J Sunderland; Andrew W Norris Journal: PLoS One Date: 2010-08-06 Impact factor: 3.240
Authors: Chunlei Wu; Camilo Orozco; Jason Boyer; Marc Leglise; James Goodale; Serge Batalov; Christopher L Hodge; James Haase; Jeff Janes; Jon W Huss; Andrew I Su Journal: Genome Biol Date: 2009-11-17 Impact factor: 13.583
Authors: Hongshu Sui; Yaling Yi; Jianrong Yao; Bo Liang; Xingshen Sun; Shanming Hu; Aliye Uc; Deborah J Nelson; Katie Larson Ode; Louis H Philipson; John F Engelhardt; Andrew W Norris Journal: PLoS One Date: 2014-03-03 Impact factor: 3.240